Valeant Says 9th Circ.'s FCA Disclosure Ruling Went Too Far
By Andrew Karpan · September 19, 2023, 5:51 PM EDT
The drugmaker behind a major bowel disease treatment said that a Ninth Circuit panel split with "at least eleven" other appeals courts when it ruled that putting together disclosures from patent...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login